Plain-English translation of NCT02890641 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for genetic mutations in the brain that cause certain types of hard-to-treat focal epilepsy in children. Researchers will collect small samples of brain tissue and blood from children who are already having epilepsy surgery, then study the DNA to find mutations that may have caused the seizures. By understanding these genetic causes, doctors hope to develop better treatments in the future.
Many children with focal epilepsy don't respond well to anti-seizure medications, and surgery is sometimes their best option. Recent discoveries show that specific genetic mutations in the brain are responsible for many of these cases, but doctors still don't fully understand all the causes. This study aims to identify these mutations so that treatment can be more precise and personalized.
You likely qualify if…
You likely don't qualify if…
If you enroll, your child will have brain tissue and blood samples collected during their scheduled epilepsy surgery at the Rothschild Foundation in Paris. Researchers will analyze the DNA from both samples to look for genetic mutations. You and your child's parents will also be asked to provide consent and participate in the study process. The samples collected during surgery will be the main part of your involvement — no extra surgery or procedures beyond what's already planned will be needed.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
France